Finance

Lists
Why is CNH down 3.42%?
Dive Deeper
CNH:NYSE
CNH Industrial NV
$13.28
-3.42%
(-0.47) 1D
$13.10
-1.36% (-0.18)
After hours
Closed: Sep 24, 4:00:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNH...
Open
$13.68
High
$13.77
Low
$13.14
Mkt. cap
16.44B
Avg. vol.
22.46M
Volume
0.00
Dividend
0.75%
Quarterly dividend
$0.03
Ex-dividend date
May 21, 2025
P/E ratio
53.17
52-wk high
$14.46
52-wk low
$9.00
EPS
$0.25
Beta
1.18
Shares outstanding
1.24B
No. of employees
34K
Open
$13.68
High
$13.77
Low
$13.14
Mkt. cap
16.44B
Avg. vol.
22.46M
Volume
0.00
Dividend
0.75%
Quarterly dividend
$0.03
Ex-dividend date
May 21, 2025
P/E ratio
53.17
52-wk high
$14.46
52-wk low
$9.00
EPS
$0.25
Beta
1.18
Shares outstanding
1.24B
No. of employees
34K
News stories
From web sources and news partners
Profile
CNH Industrial NV is an American-British multinational corporation with global headquarters in Basildon, United Kingdom, but controlled and mostly owned by the Dutch investment company Exor, which in turn is controlled by the Agnelli family. Through its various businesses, CNH Industrial designs, produces, and sells agricultural machinery and construction equipment. Present in all major markets worldwide, CNH Industrial is focused on expanding its presence in high-growth markets, including through joint ventures. In 2019 CNH Industrial employed more than 63,000 people in 67 manufacturing plants and 56 research and development centers. The company operates across 180 countries. CNH Industrial is listed on the New York Stock Exchange. The company is incorporated in the Netherlands. The seat of the company is in Amsterdam, Netherlands, with a principal office in London, England. Wikipedia
About CNH Industrial NV
CEOScott W. Wine | Gerrit Marx
Employees34.2K
Founded1842
Headquarters-
SectorMachine industry
Websitecnh.com
Analyst ratings
Based on 13 analysts giving stock ratings to CNH in the past 3 months
Buy
Buy
8
Hold
4
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CNH in the last 3 months.
Highest
Current $13.28
$18.00 (+35.54%)
Average
$13.44 (+1.20%)
Lowest
$9.00 (-32.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chad Dillard
Bernstein
Hold
Maintained
$9.00
-32.2%
09/21/2026
Ted Jackson
Northland Securities
Buy
Maintained
$16.00
+20.5%
09/11/2026
David Raso
Evercore ISI
Buy
Upgraded
$18.00
+35.5%
09/02/2026
Mircea Dobre
Robert W. Baird
Buy
Upgraded
$15.00
+13%
08/31/2026
Michael Shlisky
D.A. Davidson
Hold
Maintained
$12.00
-9.6%
08/19/2026
Angel Castillo
Morgan Stanley
Buy
Maintained
$15.00
+13%
08/04/2026
Kristen Owen
Oppenheimer
Buy
Maintained
$16.00
+20.5%
08/04/2026
Jamie Cook
Truist Financial
Buy
Reiterated
$15.00
+13%
08/04/2026
Tami Zakaria
J.P. Morgan
Sell
Maintained
$10.00
-24.7%
08/04/2026
Joel Jackson
BMO Capital
Hold
Reiterated
$12.00
-9.6%
08/04/2026
Kyle Menges
Citi
Buy
Maintained
$13.00
-2.1%
08/05/2026
Adam Seiden
Barclays
Buy
Maintained
$12.00
-9.6%
08/04/2026
Michael Feniger
Bank of America Securities
Hold
Maintained
$11.75
-11.5%
07/20/2026
Christian Hinderaker
Goldman Sachs
Hold
Downgraded
$10.50
-20.9%
05/11/2026
Steven Fisher
UBS
Buy
Maintained
$14.00
+5.4%
05/10/2026
Daniela Costa
Goldman Sachs
Buy
Reiterated
$12.00
-9.6%
03/12/2026
Last report
Aug 3, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.13 / $0.11
+22.41%beat
Revenue / Est. (USD)
4.80B / 4.75B
+1.10%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.40B
5.16B
3.83B
4.80B
Cost of goods sold
3.00B
3.63B
2.60B
3.40B
Cost of revenue
3.62B
4.20B
3.15B
3.97B
Research and development expenses
232.00M
391.00M
232.00M
230.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
381.00M
377.00M
357.00M
365.00M
Operating expense
627.00M
858.00M
569.00M
567.00M
Total operating expenses
4.25B
5.06B
3.72B
4.54B
Operating income
148.00M
97.00M
103.00M
266.00M
Other non operating income
-
-
-
-
EBT including unusual items
68.00M
149.00M
14.00M
184.00M
EBT excluding unusual items
114.00M
43.00M
18.00M
211.00M
Income tax expense
1.00M
60.00M
4.00M
43.00M
Effective tax rate
1.47%
40.27%
28.57%
23.37%
Other operating expenses
14.00M
90.00M
-20.00M
-28.00M
Net income
80.00M
86.00M
7.00M
138.00M
Net profit margin
1.82%
1.67%
0.18%
2.87%
Earnings per share
0.08
0.19
0.01
0.13
Interest and investment income
-
-
-
-
Interest expense
-39.00M
-43.00M
-33.00M
-45.00M
Net interest expenses
-39.00M
-43.00M
-33.00M
-45.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
258.00M
211.00M
219.00M
383.00M
Gain or loss from assets sale
-3.00M
3.00M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps